Baxalta Incorporated
Overview
Baxalta Incorporated was a biopharmaceutical company that focused on developing and delivering therapies for orphan diseases and underserved conditions. It is now part of Shire, which was acquired by Takeda Pharmaceutical Company. Baxalta specialized in hematology, immunology, and oncology.
Therapeutic areas
FDA compliance signals
5 FDA enforcement records linked to this company.
- 4832022-09-15
Establish reliability of supplier's C of A
- 4832022-09-15
Microbiological Contamination Exam
- 4832022-09-15
Investigations of discrepancies, failures
- 4832022-04-07
Extent of discrepancy, failure investigations
- 4832022-04-07
Validation lacking for sterile drug products
Ready to Accelerate Your
Discovery Workflow?
Find, vet, and source drug-manufacturing partners faster — with FDA compliance screening built in. Start free for 14 days.